YAP enriched in nucleus in tumour relative to healthy tissue [307]; YAP and TAZ overexpression correlates to poor survival in NSCLC patients [308,309]; YAP and TAZ maintain stemness in NSCLC cancer cells [310]. The gene discussed is YAP1; the disease is neoplasm.